|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Feng H, Ge F, Du L, Zhang Z and Liu D:
MiR-34b-3p represses cell proliferation, cell cycle progression and
cell apoptosis in non-small-cell lung cancer (NSCLC) by targeting
CDK4. J Cell Mol Med. 23:5282–5291. 2019.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Lang N, Wang C, Zhao J, Shi F, Wu T and
Cao H: Long noncoding RNA BCYRN1 promotes glycolysis and tumor
progression by regulating the miR149/PKM2 axis in nonsmallcell lung
cancer. Mol Med Rep. 21:1509–1516. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zou A, Liu X, Mai Z, Zhang J, Liu Z, Huang
Q, Wu A and Zhou C: LINC00472 acts as a tumor suppressor in NSCLC
through KLLN-mediated p53-signaling pathway via MicroRNA-149-3p and
MicroRNA-4270. Mol Ther Nucleic Acids. 17:563–577. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dai FQ, Li CR, Fan XQ, Tan L, Wang RT and
Jin H: miR-150-5p inhibits non-small-cell lung cancer metastasis
and recurrence by targeting HMGA2 and β-catenin signaling. Mol Ther
Nucleic Acids. 16:675–685. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wang W, Shen XB, Jia W, Huang DB, Wang Y
and Pan YY: The p53/miR-193a/EGFR feedback loop function as a
driving force for non-small cell lung carcinoma tumorigenesis. Ther
Adv Med Oncol. 11(1758835919850665)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Liu X, Min S, Wu N, Liu H, Wang T, Li W,
Shen Y, Zhao C, Wang H, Qian Z, et al: miR-193a-3p inhibition of
the Slug activator PAK4 suppresses non-small cell lung cancer
aggressiveness via the p53/Slug/L1CAM pathway. Cancer Lett.
447:56–65. 2019.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Che Y, Shi X, Shi Y, Jiang X, Ai Q, Shi Y,
Gong F and Jiang W: Exosomes derived from miR-143-overexpressing
MSCs inhibit cell migration and invasion in human prostate cancer
by downregulating TFF3. Mol Ther Nucleic Acids. 18:232–244.
2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Gu C, Cai J, Xu Z, Zhou S, Ye L, Yan Q,
Zhang Y, Fang Y, Liu Y, Tu C, et al: MiR-532-3p suppresses
colorectal cancer progression by disrupting the ETS1/TGM2
axis-mediated Wnt/beta-catenin signaling. Cell Death Dis.
10(739)2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Tung CH, Kuo LW, Huang MF, Wu YY, Tsai YT,
Wu JE, Hsu KF, Chen YL and Hong TM: MicroRNA-150-5p promotes cell
motility by inhibiting c-Myb-mediated Slug suppression and is a
prognostic biomarker for recurrent ovarian cancer. Oncogene.
39:862–876. 2020.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Shen GY, Ren H, Shang Q, Zhao WH, Zhang
ZD, Yu X, Huang JJ, Tang JJ, Yang ZD, Liang D and Jiang XB:
Let-7f-5p regulates TGFBR1 in glucocorticoid-inhibited osteoblast
differentiation and ameliorates glucocorticoid-induced bone loss.
Int J Biol Sci. 15:2182–2197. 2019.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tan W, Gu Z, Leng J, Zou X, Chen H, Min F,
Zhou W, Zhang L and Li G: Let-7f-5p ameliorates inflammation by
targeting NLRP3 in bone marrow-derived mesenchymal stem cells in
patients with systemic lupus erythematosus. Biomed Pharmacother.
118(109313)2019.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Li ZH, Wang YF, He DD, Zhang XM, Zhou YL,
Yue H, Huang S, Fu Z, Zhang LY, Mao ZQ, et al: Let-7f-5p suppresses
Th17 differentiation via targeting STAT3 in multiple sclerosis.
Aging (Albany NY). 11:4463–4477. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gao XR, Ge J, Li WY, Zhou WC, Xu L and
Geng DQ: NF-kappaB/let-7f-5p/IL-10 pathway involves in wear
particle-induced osteolysis by inducing M1 macrophage polarization.
Cell Cycle. 17:2134–2145. 2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shen GY, Ren H, Huang JJ, Zhang ZD, Zhao
WH, Yu X, Shang Q, Qiu T, Zhang YZ, Tang JJ, et al: Plastrum
testudinis extracts promote BMSC proliferation and osteogenic
differentiation by regulating Let-7f-5p and the TNFR2/PI3K/AKT
signaling pathway. Cell Physiol Biochem. 47:2307–2318.
2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Han L, Zhou Y, Zhang R, Wu K, Lu Y, Li Y,
Duan R, Yao Y, Zhu D and Jia Y: MicroRNA Let-7f-5p promotes bone
marrow mesenchymal stem cells survival by targeting caspase-3 in
Alzheimer disease model. Front Neurosci. 12(333)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Tie Y, Chen C, Yang Y, Qian Z, Yuan H,
Wang H, Tang H, Peng Y, Du X and Liu B: Upregulation of let-7f-5p
promotes chemotherapeutic resistance in colorectal cancer by
directly repressing several pro-apoptotic proteins. Oncol Lett.
15:8695–8702. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Di Fazio P, Maass M, Roth S, Meyer C,
Grups J, Rexin P, Bartsch DK and Kirschbaum A: Expression of
hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative
targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors
of the lung. Tumour Biol. 39(1010428317728417)2017.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chang J, Huang L, Cao Q and Liu F:
Identification of colorectal cancer-restricted microRNAs and their
target genes based on high-throughput sequencing data. Onco Targets
Ther. 9:1787–1794. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cui J, Huang W, Wu B, Jin J, Jing L, Shi
WP, Liu ZY, Yuan L, Luo D, Li L, et al: N-glycosylation by
N-acetylglucosaminyltransferase V enhances the interaction of
CD147/basigin with integrin beta1 and promotes HCC metastasis. J
Pathol. 245:41–52. 2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhao G, Gong L, Su D, Jin Y, Guo C, Yue M,
Yao S, Qin Z, Ye Y, Tang Y, et al: Cullin5 deficiency promotes
small-cell lung cancer metastasis by stabilizing integrin β1. J
Clin Invest. 129:972–987. 2019.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wang X, Zhou Q, Yu Z, Wu X, Chen X, Li J,
Li C, Yan M, Zhu Z, Liu B and Su L: Cancer-associated
fibroblast-derived Lumican promotes gastric cancer progression via
the integrin beta1-FAK signaling pathway. Int J Cancer.
141:998–1010. 2017.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Izumi D, Ishimoto T, Miyake K, Sugihara H,
Eto K, Sawayama H, Yasuda T, Kiyozumi Y, Kaida T, Kurashige J, et
al: CXCL12/CXCR4 activation by cancer-associated fibroblasts
promotes integrin beta1 clustering and invasiveness in gastric
cancer. Int J Cancer. 138:1207–1219. 2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Wu JI, Lin YP, Tseng CW, Chen HJ and Wang
LH: Crabp2 promotes metastasis of lung cancer cells via HuR and
integrin β1/FAK/ERK signaling. Sci Rep. 9(845)2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong
Q, Qin L, Wu X, Zheng Y, Yang Y, et al: Identification of miRNomes
in human liver and hepatocellular carcinoma reveals miR-199a/b-3p
as therapeutic target for hepatocellular carcinoma. Cancer Cell.
19:232–243. 2011.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Han Z, Zhu Y, Cui Z, Guo P, Wei A and Meng
Q: MicroRNA Let-7f-1-3p attenuates smoke-induced apoptosis in
bronchial and alveolar epithelial cells in vitro by targeting
FOXO1. Eur J Pharmacol. 862(172531)2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kim EJ, Kim JS, Lee S, Lee H, Yoon JS,
Hong JH, Chun SH, Sun S, Won HS, Hong SA, et al: QKI, a miR-200
target gene, suppresses epithelial-to-mesenchymal transition and
tumor growth. Int J Cancer. 145:1585–1595. 2019.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhang DD, Li Y, Xu Y, Kim J and Huang S:
Phosphodiesterase 7B/microRNA-200c relationship regulates
triple-negative breast cancer cell growth. Oncogene. 38:1106–1120.
2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Han J, Wang F, Lan Y, Wang J, Nie C, Liang
Y, Song R, Zheng T, Pan S, Pei T, et al: KIFC1 regulated by
miR-532-3p promotes epithelial-to-mesenchymal transition and
metastasis of hepatocellular carcinoma via gankyrin/AKT signaling.
Oncogene. 38:406–420. 2019.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Desgrosellier JS and Cheresh DA: Integrins
in cancer: Biological implications and therapeutic opportunities.
Nat Rev Cancer. 10:9–22. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Chen MB, Lamar JM, Li R, Hynes RO and Kamm
RD: Elucidation of the roles of tumor integrin β1 in the
extravasation stage of the metastasis cascade. Cancer Res.
76:2513–2524. 2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kren A, Baeriswyl V, Lehembre F, Wunderlin
C, Strittmatter K, Antoniadis H, Fässler R, Cavallaro U and
Christofori G: Increased tumor cell dissemination and cellular
senescence in the absence of beta1-integrin function. EMBO J.
26:2832–2842. 2007.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Assoian RK and Klein EA: Growth control by
intracellular tension and extracellular stiffness. Trends Cell
Biol. 18:347–352. 2008.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Xu F, Liao JZ, Xiang GY, Zhao PX, Ye F,
Zhao Q and He XX: MiR-101 and doxorubicin codelivered by liposomes
suppressing malignant properties of hepatocellular carcinoma.
Cancer Med. 6:651–661. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Gong C, Tian J, Wang Z, Gao Y, Wu X, Ding
X, Qiang L, Li G, Han Z, Yuan Y and Gao S: Functional
exosome-mediated co-delivery of doxorubicin and hydrophobically
modified microRNA 159 for triple-negative breast cancer therapy. J
Nanobiotechnology. 17(93)2019.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Zhang S, Han L, Wei J, Shi Z, Pu P, Zhang
J, Yuan X and Kang C: Combination treatment with doxorubicin and
microRNA-21 inhibitor synergistically augments anticancer activity
through upregulation of tumor suppressing genes. Int J Oncol.
46:1589–1600. 2015.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Bolandghamat Pour Z, Nourbakhsh M,
Mousavizadeh K, Madjd Z, Ghorbanhosseini SS, Abdolvahabi Z, Hesari
Z and Ezzati Mobasser S: Suppression of nicotinamide
phosphoribosyltransferase expression by miR-154 reduces the
viability of breast cancer cells and increases their susceptibility
to doxorubicin. BMC Cancer. 19(1027)2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Wang YF, Ao X, Liu Y, Ding D, Jiao WJ, Yu
Z, Zhai WX, Dong SH, He YQ, Guo H and Wang JX: MicroRNA-608
promotes apoptosis in non-small cell lung cancer cells treated with
doxorubicin through the inhibition of TFAP4. Front Genet.
10(809)2019.PubMed/NCBI View Article : Google Scholar
|
